Waking up with blurred vision and pain when you move your eye is frightening. Optic neuritis is serious. But it is treatable, and most people recover most of their vision. What matters is acting quickly and understanding what comes next.

Optic neuritis is an inflammation of the optic nerve, the cable that carries visual signals from the eye to the brain. It typically causes sudden vision loss in one eye, often accompanied by pain that worsens with eye movement, and reduced colour perception. It most commonly affects young adults between 20 and 40, with a strong predisposition for women. Optic neuritis matters not only because of the vision loss it causes, which usually recovers well, but because it is frequently the first presenting symptom of multiple sclerosis. Understanding what it means for long-term neurological health is as important as treating the acute episode.

What You Need to Know About Optic Neuritis

Optic neuritis causes sudden vision loss in one eye, pain on eye movement, and washed-out colour perception, developing over hours to days
Most patients recover most of their vision within weeks to months, often without treatment
Intravenous steroids speed recovery but do not improve the final visual outcome
Around 50 percent of people presenting with a first episode of optic neuritis will develop multiple sclerosis within 15 years
MRI of the brain at the time of optic neuritis is the most important predictor of MS risk and guides decisions about disease-modifying treatment
Recurrent optic neuritis or optic neuritis that doesn’t recover well should raise suspicion for NMOSD and MOG antibody disease

Visual recovery ~90% Of patients recover vision to 20/40 or better within 6 months

MS risk at 15 years ~50% Of optic neuritis patients develop MS over 15 years

Most affected Women 20-40 Years old, though it can occur at any age

Symptoms

Vision loss

The vision loss of optic neuritis develops over hours to a few days and ranges from mild blurring to severe reduction. It is almost always monocular, affecting one eye, in typical demyelinating optic neuritis. Central vision is most prominently affected, often producing a dark or blurred patch at the center of the visual field. Side vision is usually better preserved.

Side-by-side comparison of vision in optic neuritis: left image shows the affected eye's view with a dark central scotoma and washed-out colors; right image shows the same scene through the normal eye with full clarity — Left: vision through an eye with acute optic neuritis, with central blurring and reduced colour. Right: the same scene through the unaffected eye.

Pain

Pain with eye movement is present in around 90 percent of patients and is often the first symptom, sometimes preceding the vision loss by a day or two. It’s typically described as an aching or pressure sensation behind the eye that worsens when the eyes move, particularly in extreme gaze. The pain usually resolves within a couple of weeks regardless of treatment.

Colour desaturation

Even when visual acuity appears relatively preserved, patients with optic neuritis characteristically notice that colours look washed out or less vivid in the affected eye. Red objects in particular look duller or less saturated than through the normal eye. This red desaturation is a clinically important sign and often persists even after visual acuity has fully recovered, because fine colour transmission requires intact optic nerve function beyond simple acuity.

Uhthoff’s phenomenon

Many patients notice their vision temporarily worsens with exercise, hot showers, or fever. This is Uhthoff’s phenomenon: raised body temperature further impairs conduction in already inflamed nerve fibres. It is benign and reverses once the body cools. Alarming if you don’t know to expect it. It does not indicate that the nerve is being further damaged. Worth knowing before a summer run puts you through it unexpectedly.

Diagnosis

Clinical examination

The diagnosis is primarily clinical. The ophthalmologist assesses visual acuity, colour vision, the visual field, and the relative afferent pupillary defect (RAPD), a difference in the pupil’s response to light between the two eyes that indicates reduced optic nerve function on the affected side. In typical optic neuritis the optic disc looks normal on examination because the inflammation is usually behind the eye. OCT of the retinal nerve fibre layer provides an objective baseline measurement of optic nerve fibre thickness, which will thin during recovery as damaged fibres are lost.

MRI

MRI of the brain and orbits is performed in all patients with optic neuritis. It serves two purposes: confirming the diagnosis by showing signal change along the optic nerve, and assessing the brain for white matter lesions that indicate subclinical demyelination and push the risk of developing MS considerably higher.

Axial brain MRI at orbital level showing both optic nerves, with the left optic nerve shown on the right side of the image displaying a red-orange glow illustrating the site of inflammation in optic neuritis — Axial MRI at orbital level. The red glow on the right side of the image is an illustration added to highlight the affected nerve. On an actual MRI scan, the finding is a subtle signal change along the nerve length, not visible as a glow.

Blood tests

MOG and AQP4 antibodies are measured in all patients, particularly those with atypical features, because MOG antibody disease and NMOSD require different long-term management from MS-associated optic neuritis. Vitamin B12, inflammatory markers, and ACE level are checked where clinically indicated.

Treatment

Intravenous methylprednisolone

The standard treatment for acute optic neuritis is a three to five day course of high-dose intravenous methylprednisolone. This speeds the rate of visual recovery by approximately two to four weeks compared to no treatment, allowing patients to return to normal activities sooner. The landmark Optic Neuritis Treatment Trial established clearly that steroids do not improve the final level of vision achieved. The outcome at six months and beyond is the same whether or not steroids are given. The decision to treat depends on how severely the vision loss is affecting daily life.

Oral prednisolone alone at standard doses is not recommended because the original trial showed an unexpectedly higher rate of recurrence in the oral steroid group. If oral steroids are used, they should follow rather than replace the intravenous course.

Disease-modifying treatment for MS

For patients whose MRI shows white matter lesions indicating high MS risk, early referral to neurology for consideration of disease-modifying therapy is important. The CHAMPS and CHAMPIONS trials showed that starting a disease-modifying drug after a first demyelinating event cuts the risk of a second event substantially and delays the diagnosis of clinically definite MS. The decision is made jointly by the neurologist and patient based on MRI findings, personal circumstances, and tolerance of risk.

Optic Neuritis and Multiple Sclerosis

Every single patient asks this question. Having a single episode of optic neuritis does not mean you will develop MS, but it does mean your risk is elevated above the general population. How much elevated depends enormously on what the MRI shows.

In the Optic Neuritis Treatment Trial, patients with no white matter lesions on MRI at the time of optic neuritis had only a 25 percent risk of developing MS over 15 years. Patients with two or more white matter lesions had a risk of around 72 percent. The MRI is not just a diagnostic test. It is a prognostic one, and its findings drive all decisions about monitoring and preventive treatment.

MS-associated optic neuritis has a better prognosis for visual recovery than NMOSD or MOG antibody disease. If your antibody tests are negative and your MRI is consistent with demyelination, that is the form of optic neuritis with the best visual outlook. Discussing your specific results with your ophthalmologist and neurologist gives you the clearest picture of your individual situation.

Seek Urgent Assessment the Same Day If You Have

Sudden vision loss in one eye, with or without pain on eye movement
Sudden loss of vision in both eyes simultaneously, which is atypical and needs urgent exclusion of other causes
Vision loss that is rapidly worsening over hours
A known optic neuritis patient whose vision deteriorates again after a period of recovery
Optic neuritis alongside limb weakness, sensory disturbance, or difficulty with balance

Optic neuritis requires same-day assessment to confirm the diagnosis, exclude other causes of sudden vision loss such as retinal detachment or vascular occlusion, and arrange urgent MRI and neurology review. Don’t wait for a routine appointment. Contact your eye unit or go to an emergency eye service the same day.

Frequently Asked Questions About Optic Neuritis

Will my vision fully recover?
In most cases, yes. Around 90 percent of patients with typical demyelinating optic neuritis recover vision to 20/40 or better within six months, and many recover to 20/20. Recovery begins within the first few weeks and continues for up to a year. Patience matters here. Even with good acuity recovery, some residual symptoms often persist, particularly subtle colour desaturation and Uhthoff’s phenomenon with heat or exercise. These reflect incomplete remyelination but they don’t indicate ongoing damage to the nerve.
Do I need steroids?
Steroids speed recovery but don’t change the final outcome. If your vision loss is mild and not badly affecting your daily life, watchful waiting and natural recovery is entirely reasonable. If the vision loss is severe, or if you have work or driving demands that make early recovery important, intravenous steroids are worth discussing. The decision should be made with full information about what steroids can and cannot achieve.
Does optic neuritis mean I have MS?
Not necessarily. A single episode raises your lifetime risk but doesn’t confirm the diagnosis. The key prognostic test is the brain MRI. No white matter lesions means a 15-year MS risk of around 25 percent. Multiple lesions means the risk is much higher. Your neurologist will use the MRI findings, clinical features, and antibody results to give you a clearer personal risk estimate and advise on whether early preventive treatment is appropriate.
Why does my vision get worse when I exercise or have a hot shower?
Uhthoff’s phenomenon. Raising body temperature impairs conduction in nerve fibres that are inflamed or incompletely remyelinated. The effect is temporary and reverses once the body cools. It doesn’t cause any additional damage to the nerve. It can persist for months or years after the acute episode. Worth knowing before the next gym session.
Can optic neuritis happen again?
Yes. Recurrence in the same or fellow eye is possible, particularly in patients who go on to develop MS. Very severe optic neuritis that doesn’t recover well, or recurrence in the same eye, should prompt retesting for MOG antibody disease and NMOSD, as these are prone to recurrence and require different preventive treatment. If you’ve had optic neuritis before and notice new visual symptoms, get assessed promptly. Don’t assume it will follow the same course. It may not.
Is there anything I can do to protect my optic nerve long-term?
For patients at high MS risk based on MRI findings, disease-modifying therapy started early after a first episode reduces relapse rates and slows brain lesion accumulation. Beyond this, general measures that support neurological health apply: regular exercise, not smoking, adequate vitamin D, and a healthy weight all have evidence linking them to better MS outcomes. Discuss what is relevant to your specific risk profile with your neurologist.

If you would like to learn more, the NCBI StatPearls review on optic neuritis offers a detailed medical overview of causes, symptoms, diagnosis, imaging, and treatment, while the North American Neuro-Ophthalmology Society page on optic neuritis provides a patient-friendly explanation of symptoms, MRI evaluation, treatment, prognosis, and the link with multiple sclerosis.